申请人:ELI LILLY AND COMPANY
公开号:EP0555036A2
公开(公告)日:1993-08-11
This invention provides the use of N-[[(3,4-dichlorophenyl)amino]carbonyl]-2,3-dihydrobenzofuran-5-sulfonamide, and pharmaceutically acceptable salts thereof, in the treatment of susceptible neoplasms in mammals. This invention further provides the novel aforementioned compound and its pharmaceutical formulations.
本发明提供了 N-[[(3,4-二氯苯基)氨基]羰基]-2,3-二氢苯并呋喃-5-磺酰胺及其药学上可接受的盐在治疗哺乳动物易感肿瘤中的用途。本发明进一步提供了上述新型化合物及其药物制剂。